Crossref
Correction to “Morpholino Pyrimidine/Pyrimidino‐Oxazines: An Integrated Study as DGAT1 Inhibitors Through QSAR, Molecular Docking, ADMET, and Computational Simulation”
ChemistrySelect · 2026-05 · 11 (19)
DOI: 10.1002/slct.73527 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemistrySelect, online erschienen am 19.05.2026.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Correction to “Morpholino Pyrimidine/Pyrimidino‐Oxazines: An Integrated Study as DGAT1 Inhibitors Through QSAR, Molecular Docking, ADMET, and Computational Simulation”. ChemistrySelect, 11(19). https://doi.org/10.1002/slct.73527
Vancouver
Correction to “Morpholino Pyrimidine/Pyrimidino‐Oxazines: An Integrated Study as DGAT1 Inhibitors Through QSAR, Molecular Docking, ADMET, and Computational Simulation”. ChemistrySelect. 2026;11(19). doi:10.1002/slct.73527
BibTeX
@article{euvimed2026,
title = {Correction to “Morpholino Pyrimidine/Pyrimidino‐Oxazines: An Integrated Study as DGAT1 Inhibitors Through QSAR, Molecular Docking, ADMET, and Computational Simulation”},
journal = {ChemistrySelect},
year = {2026},
volume = {11},
number = {19},
doi = {10.1002/slct.73527}
}
EUVIMED